We are live on ! Find out more

518 hedge funds and large institutions have $5.95B invested in Chemed in 2025 Q4 according to their latest regulatory filings, with 71 funds opening new positions, 157 increasing their positions, 223 reducing their positions, and 67 closing their positions.

New
Increased
Maintained
Reduced
Closed

3.4% more ownership

Funds ownership: 94.3%97.7% (+3.4%)

6% more first-time investments, than exits

New positions opened: 71 | Existing positions closed: 67

1% less funds holding

Funds holding: 523518 (-5)

3% less capital invested

Capital invested by funds: $6.15B → $5.95B (-$200M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

30% less repeat investments, than reductions

Existing positions increased: 157 | Existing positions reduced: 223

58% less call options, than puts

Call options by funds: $1.67M | Put options by funds: $3.98M

Holders
518
Holders Change
-5
Holders Change %
-0.96%
% of All Funds
6.27%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
71
Increased
157
Reduced
223
Closed
67
Calls
$1.67M
Puts
$3.98M
Net Calls
-$2.31M
Net Calls Change
-$693K

CHE Hedge Fund Activity: Q4 2025 in Review

518 of the 8,264 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q4 2025, worth a combined $5.95B — down 3.2% from $6.15B a quarter earlier.

Buyers outnumbered sellers: 71 funds opened new CHE positions and 67 closed out — a net gain of 4 holders — while 157 added to existing stakes and 223 trimmed.

The largest buyer was AQR Capital Management, adding an estimated $66.8M. The largest seller was Morgan Stanley, cutting an estimated $39.4M.

  • 518 institutional investors held Chemed (CHE) as of Q4 2025, down from 523 in Q3 2025.
  • Funds reported $5.95B of Chemed stock for Q4 2025, down 3.2% quarter-over-quarter.
  • 71 funds opened new Chemed positions in Q4 2025 and 67 closed out, a net change of +4 holders.
  • The largest Chemed buyer in Q4 2025 was AQR Capital Management, an estimated $66.8M added.
  • The largest Chemed seller in Q4 2025 was Morgan Stanley, an estimated $39.4M sold.

Based on aggregated 13F filings for Q4 2025.